Fleisch J H, Haisch K D, Spaethe S M
J Pharmacol Exp Ther. 1982 Apr;221(1):146-51.
A dual isolated organ technique comprised of a guinea-pig lung parenchymal strip and a guinea-pig ileum was used to determine if slow reacting substance of anaphylaxis (SRS-A) is released from parenchyma during contractions evoked by antigen (ovalbumin) or by ionophore (A23187). An immunologically sensitized parenchyma served as the primary target organ for ovalbumin and either a sensitized or unsensitized parenchyma was the target tissue for A23187; an unsensitized ileum functioned as the assay organ. In the presence of pyrilamine and indomethacin, ovalbumin or A23187 produced contractions of the parenchyma and concomitantly caused release of SRS-A from the lung strip which was indicated by a contraction of the ileum. The ileal response was antagonized by FPL 55712, whereas the parenchyma contractions were unaffected. Additional experiments were conducted in which parenchyma was contracted with histamine. At the height of the histamine contraction, the bathing fluid surrounding the parenchyma was removed and assayed on a pyrilamine-treated ileum. SRS-A was not detected, indicating that SRS-A release from parenchyma is not a function of tissue contraction per se, but is related to the antigen- and ionophore-induced contractions. To explain the lack of effect of FPL 55712 on parenchymal contractions to antigen or ionophore, we compared the degree of antagonism produced by FPL 55712 on SRS-A contraction of parenchyma and ileum. These experiments indicated the possibility that at least two different classes of SRS-A receptors exist and that those in the ileum and lung differ.
采用一种由豚鼠肺实质条和豚鼠回肠组成的双分离器官技术,以确定在抗原(卵清蛋白)或离子载体(A23187)诱发的收缩过程中,过敏反应慢反应物质(SRS-A)是否从实质组织中释放。经免疫致敏的实质组织作为卵清蛋白的主要靶器官,而致敏或未致敏的实质组织则是A23187的靶组织;未致敏的回肠作为检测器官。在存在吡拉明和吲哚美辛的情况下,卵清蛋白或A23187使实质组织收缩,并同时导致肺条释放SRS-A,这通过回肠收缩得以表明。回肠反应可被FPL 55712拮抗,而实质组织收缩不受影响。还进行了其他实验,其中用组胺使实质组织收缩。在组胺收缩达到高峰时,去除实质组织周围的灌流液,并在经吡拉明处理的回肠上进行检测。未检测到SRS-A,这表明实质组织释放SRS-A并非组织收缩本身的作用,而是与抗原和离子载体诱导的收缩有关。为了解释FPL 55712对实质组织对抗原或离子载体收缩缺乏作用的原因,我们比较了FPL 55712对实质组织和回肠SRS-A收缩产生的拮抗程度。这些实验表明,至少存在两类不同的SRS-A受体,且回肠和肺中的受体不同。